Crinetics director granted stock and options
Crinetics Pharmaceuticals director Wendell Wierenga received new equity awards in the form of stock and options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Crinetics Pharmaceuticals director Wendell Wierenga received new equity awards in the form of stock and options. He was granted 5,925 shares of Common Stock as restricted stock units at no cost, bringing his direct holdings to 122,071 shares after the grant.
He also received a stock option covering 9,730 shares of Common Stock with an exercise price of $35.87 per share and an expiration date in 2036. Both the restricted stock units and the option vest 100% on the earlier of the first anniversary of the June 18, 2026 grant date or the next annual stockholder meeting, subject to his continued service on the board.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 9,730 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,925 | $0.00 | $0.00 |
Footnotes (2)
- F1. The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
- F2. The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
Key Figures
Key Terms
restricted stock units financial
stock option financial
exercise price financial
vest financial
annual meeting of the Issuer's stockholders regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did CRNX director Wendell Wierenga receive in this Form 4?
What is the exercise price and term of the new Crinetics (CRNX) stock option?
When do the new CRNX restricted stock units for Wendell Wierenga vest?
What are the vesting terms of the new Crinetics (CRNX) stock option?
AI-generated analysis. How Rhea-AI works. Not financial advice.